Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer

Abstract

Fractalkine expression by C26 tumour cells drastically reduces their metastatic potential in the two physiological target organs. Both molecular forms contribute to its antitumour potential but exhibit differential effects on tumour development depending on the target tissue.